StockData
Oculis Holding AG logo

Oculis Holding AG (OCS) stock

OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.51−0.12 (-1.57%)

Close on Nov 17, 2026Market cap $451.27MP/E –Yield –

Oculis pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Oculis

Oculis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Oculis figures

See a number that looks wrong?